Last summer, Cerbios-Pharma SA (from now on “Cerbios”) commissioned SafeBridge Europe, Ltd. (from now on “SafeBridge”) to carry out a surrogate containment performance assessment of three isolators located in P5 manufacturing unit at Cerbios site located in Lugano, Switzerland.